Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suneel Gupta

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Journal of Public Affairs|January 30, 2023
Reputational impact of Covid-19 pandemic management on World Health Organization among Indian public health professionalsSuneel Gupta, Neerja Pande, Thangaraja Arumugam, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorderSharon B Wigal, Suneel Gupta, Erica Heverin, et al.
European Journal of Haematology|May 24, 2024
Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human studyNishit B Modi, Richard Shames, Jason D Lickliter, et al.
Current Medical Research and Opinion|December 22, 2005
Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applicationsGayatri Sathyan, Cindy Guo, Krishna Sivakumar, et al.
Journal of Clinical Pharmacology|April 10, 2015
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®))Ann Hsu, Hsuan-Ming Yao, Suneel Gupta, et al.
Biometrics|September 17, 2002
Estimation and inference for a spline-enhanced population pharmacokinetic modelLang Li, Morton B Brown, Kyung-Hoon Lee, et al.
Clinical Neuropharmacology|December 3, 2015
Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy VolunteersHsuan-Ming Yao, Ann Hsu, Suneel Gupta, et al.
Parkinson'S Disease|November 15, 2018
Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor FluctuationsJohn C Morgan, Rohit Dhall, Robert Rubens, et al.
Clinical Neuropharmacology|December 7, 2018
Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa CapsulesNishit B Modi, Aravind Mittur, Robert Rubens, et al.
Clinical Neuropharmacology|July 16, 2019
Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor FluctuationsNishit B Modi, Aravind Mittur, Phillip Dinh, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Public Affairs|January 30, 2023
Reputational impact of Covid-19 pandemic management on World Health Organization among Indian public health professionalsSuneel Gupta, Neerja Pande, Thangaraja Arumugam, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorderSharon B Wigal, Suneel Gupta, Erica Heverin, et al.
European Journal of Haematology|May 24, 2024
Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human studyNishit B Modi, Richard Shames, Jason D Lickliter, et al.
Current Medical Research and Opinion|December 22, 2005
Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applicationsGayatri Sathyan, Cindy Guo, Krishna Sivakumar, et al.
Journal of Clinical Pharmacology|April 10, 2015
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®))Ann Hsu, Hsuan-Ming Yao, Suneel Gupta, et al.
Biometrics|September 17, 2002
Estimation and inference for a spline-enhanced population pharmacokinetic modelLang Li, Morton B Brown, Kyung-Hoon Lee, et al.
Clinical Neuropharmacology|December 3, 2015
Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy VolunteersHsuan-Ming Yao, Ann Hsu, Suneel Gupta, et al.
Parkinson'S Disease|November 15, 2018
Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor FluctuationsJohn C Morgan, Rohit Dhall, Robert Rubens, et al.
Clinical Neuropharmacology|December 7, 2018
Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa CapsulesNishit B Modi, Aravind Mittur, Robert Rubens, et al.
Clinical Neuropharmacology|July 16, 2019
Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor FluctuationsNishit B Modi, Aravind Mittur, Phillip Dinh, et al.
Pageof 9